Powered by

Cumberland Pharmaceuticals, Vanderbilt University Assigned Patent for Treating Muscular Dystrophy

Nov 02, 2019 - Targeted News Service

ALEXANDRIA, Va., Nov. 2 -- Cumberland Pharmaceuticals, Nashville, Tennessee, and Vanderbilt University, Nashville, Tennessee, have been assigned a patent (No. 10,456,380, initially filed Jan. 4, 2019) developed by four co-inventors for "compositions and methods of treating muscular dystrophy with thromboxane-A.sub.2 receptor antagonists." The co-inventors are Leo Pavliv, Cary, North Carolina, James West, Nashville, Tennessee, Ines Macias Perez, Mount Juliet, Tennessee, and Erica Carrier, Nashvil...